New research reported by WIRED overturns the idea that ovaries become inert after menopause. Francesca Duncan, a reproductive biologist at Northwestern University, found that ovaries from postmenopausal women aged 50 to 75 have molecular signatures that differ significantly across decades. 'Clearly something is still happening,' she says. The finding is part of a broader effort to understand the ovary as an organ that affects overall health and aging long after fertility ends.
The business angle is still taking shape. Jennifer Garrison, an ovarian aging expert and founder of a women's health biotech company in stealth mode, says scientists know little about what the ovary does outside of fertility. That knowledge gap could matter commercially as companies seek therapies for aging-related conditions. There are already clinical stakes: Mayo Clinic epidemiologist Walter Rocca says that, barring high ovarian cancer risk, removing ovaries even after menopause is not advisable, citing evidence of increased risks of dementia, cardiovascular disease, and premature death.
At the same time, researchers caution that much is unknown. Stephanie Faubion of the Menopause Society says, 'We just have huge gaps' about how long the ovary's importance persists and how much it varies among women. Mouse studies by Duncan's team suggest older ovaries become more inflammatory and may be more prone to age-related disease, but translating that into products or treatment guidelines remains early. The WIRED report contains no conflicting sources; its main uncertainty is scientific, not commercial.